SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

SVB Leerink Maintains Market Perform on Intersect ENT, Lowers Price Target to $21

SVB Leerink maintains Intersect ENT (NASDAQ:XENT) with a Market Perform and lowers the price target from $23 to $21.

05/11/2021 12:55
SVB Leerink maintains Intersect ENT (NASDAQ:XENT) with a Market Perform and lowers the price target from $23 to $21.